P

Paion
PA8K

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€71.34K
EV
-
Shares Outstanding
7.13M
Beta
1.71

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E 2023E
-
P/Revenue 2023E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Paion AG

gainify

P

Paion AG

PA8K

Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and intensive care medicine services worldwide. The company’s lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedativ...

Sector

Industry

CEO

Siebert, Gregor

Employees

64

IPO Date

Headquarters

Heussstrasse 25, Aachen, North Rhine-Westphalia, 52078, Germany

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.